Skip to main content

Table 1 Respondent Characteristics, N = 598 (unless otherwise noted)

From: Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation

Characteristic

Full Sample

(N = 598)

All respondents

 Age, mean (SD), years

40.9 (8.2)

 Age 40 years or older

335 (56%)

 Has children

416 (70%)

 Hopes to have children in future (after mutation identified) or undecideda

268 (45%)

 White or Caucasian

558 (93%)

 Married/living as married/civil partnership

440 (74%)

 Higher education (defined as post-secondary/any college and higher)

401 (67%)

 Employed full time

329 (55%)

Country of residence

 United States

331 (55%)

 United Kingdom

117 (20%)

 Australia

119 (20%)

 Canada

31 (5%)

Mutation

BRCA1

310 (52%)

BRCA2

273 (46%)

BRCA1 and BRCA2

8 (1%)

 Don’t know or not sure

7 (1%)

Mean time since genetic test, years (SD)

4.8 (4.3)

First degree relative with breast cancer

374 (63%)

First degree relative with ovarian cancer

122 (20%)

Risk-reducing treatments

 RRBM only

95 (16%)

 RRBSO only

112 (19%)

 RRBM and RRBSO

198 (33%)

Has taken a prescription medication, such as tamoxifen, raloxifene, or an aromatase inhibitor [anastrazole, exemestane]

33 (6%)

Among women who did not report RRBM surgery

 n

305

 Very likely or somewhat likely to undergo RRBM in the futureb

193 (63%)

Among women who did not report RRBSO surgery

 n

288

 Very likely or somewhat likely to undergo RRBSO in the futurec

255 (89%)

All respondents

 nd

587

 Assigned to Susan, age 25 years

285 (48%)

 Assigned to Susan, age 36 years

302 (51%)

  1. RRBM Risk-reducing bilateral mastectomy, RRBSO Bilateral salpingo oophorectomy, SD Standard deviation
  2. a Includes women who indicated that they wanted to have children or have more children in the future or were undecided about having children or having more children and women who have children that were born after their BRCA 1 or BRCA2 mutation was identified
  3. b Based on the question “How likely are you to have a surgery to remove both breasts (risk-reducing bilateral mastectomy) in the future?” with the response choices very likely, somewhat likely, unlikely, very unlikely, don’t know or not sure
  4. c Based on the question “How likely are you to get your ovaries and fallopian tubes removed in the future?” with the response choices very likely, somewhat likely, unlikely, very unlikely, don’t know or not sure
  5. dThree respondents did not complete the full survey, thus were not assigned to a Susan age group and did not answer any of the four Susan treatment sequencing questions. An additional four respondents assigned to Susan, age 25 and four respondents assigned to Susan, age 36 also did not answer any of the four Susan treatment sequencing questions presented in the survey. Thus, these 11 respondents are not included in the two Susan group sample totals summarized in Table 1 and were not included in the Susan treatment sequence analysis presented in this article